Fol. Biol. 2010, 56, 72-77
https://doi.org/10.14712/fb2010056020072
Leflunomide Derivate FK 778 in Accelerated Renal Injury in Transgenic Rat
References
1. , A. C., Eugui, E. M. (2005) Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80, 181-190.
<https://doi.org/10.1097/01.tp.0000186390.10150.66>
2. , S., Rajnoch, J., Lodererova, A., Honsova, E., Viklicky, O. (2006) Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat. Kidney Blood Press. Res. 29, 60-66.
<https://doi.org/10.1159/000092948>
3. , K. E., Ysebaert, D. K., Vercauteren, S. R., Chapelle, T., Roeyen, G., Bosmans, J. L., Verpooten, G. A., De Broe, M. E. (2002) Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Transplant. Proc. 34, 791-794.
<https://doi.org/10.1016/S0041-1345(01)02912-8>
4. , T., Schrepfer, S., Reichenspurner, H. (2003) Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model. Transplantation 76, 1627-1629.
<https://doi.org/10.1097/01.TP.0000092006.43818.B0>
5. , T., Schrepfer, S., Schafer, H., Koch-Nolte, F., Schwedhelm, E., Boger, R. H., Reichenspurner, H. (2004) FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies. Transplantation 78, 71-77.
<https://doi.org/10.1097/01.TP.0000128629.53843.14>
6. , W. E., First, M. R. (2004) FK778, a synthetic malononitrilamide. Yonsei Med. J. 45, 1132-1135.
<https://doi.org/10.3349/ymj.2004.45.6.1132>
7. , J., Huang, H., Deng, M., Wagner, B., Roos, M., Schmaderer, C., Strobl, M., Heemann, U. (2007) The effect of FK778 on the progression of chronic allograft nephropathy in a rat model. Transplantation 83, 741-746.
<https://doi.org/10.1097/01.tp.0000255558.02582.ce>
8. , F., Ebbs, A., Wynn, C., Ericsson, L., Jang, M. S., Crews, G., Fisniku, O., Kobayashi, M., Paul, L. C., Benediktsson, H., Jiang, A. H. (2003) FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts. Transplantation 75, 1110-1114.
<https://doi.org/10.1097/01.TP.0000063704.19149.E3>
9. , J., Lodererova, A., Szabo, A., Honsova, E., Vannay, A., Bloudickova, S., Matl, I., Viklicky, O. (2005) Regulators of angiogenesis in renal ischemia/reperfusion injury in normotensive and hypertensive rats: effect of tacrolimus. Transplant. Proc. 37, 352-354.
<https://doi.org/10.1016/j.transproceed.2004.12.154>
10. , J. M., Savikko, J., Rintala, S. E., von Willebrand, E. (2006) The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-β expression. Transplant. Proc. 38, 3239-3240.
<https://doi.org/10.1016/j.transproceed.2006.10.051>
11. , S., Deuse, T., Schafer, H., Reichenspurner, H. (2005) FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival. Transpl. Int. 18, 215-220.
<https://doi.org/10.1111/j.1432-2277.2004.00044.x>
12. , S., Deuse, T., Koch-Nolte, F., Detter, C., Reichenspurner, H. (2006) FK778 new cellular and molecular mechanisms of action. Transplant. Proc. 38, 757-761.
<https://doi.org/10.1016/j.transproceed.2006.01.058>
13. , O., Bohmova, R., Ouyang, N., Honsova, E., Lodererova, A., Mandys, V., Vitko, S., Lutz, J., Hermann U. W. (2004) Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats. Transpl. Int. 17, 432-441.
14. , M. D., Wang, S. Q., Juany, W., Ma, A., Xu, D., Bekersky, I., Fitzsimmons, W. E., Wu, J., Chen, H. (2003) Combination therapy of malonitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. Transplantation 75, 1455-1459.
<https://doi.org/10.1097/01.TP.0000058811.25785.F4>
